BayHelix and Elsevier, Inc. Announce Four China Drug Development Awards

Published: Sep 27, 2012

by Richard Daverman, PhD

September 26, 2012 -- To honor innovative drug development in China, the BayHelix Group and Elsevier Business Intelligence selected four companies and individuals for the 2012 BayHelix-Elsevier Awards, recognizing significant achievements in four different areas of pharmaceutical development. The winners were: Professor Ningshao Xia and his team at Xiamen University for the first Hepatitis E vaccine; the Hutchison MediPharma/Astra Zeneca cancer drug partnership; ZheJiang BetaPharma’s launch of its cancer drug and its innovative pricing plan; and Steve Yang of Lilly for his international leadership. More details....

Stock Symbol: (NYSE: LLY)

Back to news